Login to Your Account

Other News To Note

Wednesday, June 19, 2013
• Immunogenes AG, of Zug, Switzerland, and Corvinius Kockazati Tokealap-kezelo Zrt, of Budapest, Hungary, formed a joint venture to fund the establishment for a scientific facility to develop and produce monoclonal and polyclonal antibodies and genetically modified animals in Godollo, Hungary.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription